Current Status and Future Perspectives of Endocrine Therapy for Breast Cancer: From Classical Approaches to the Evolution of Precision Systemic Medicine
Current Research in Medical Sciences · 28.04.2026 · 5 (2) · 55-60
DOI: 10.63593/crms.2026.03.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Research in Medical Sciences, online erschienen am 28.04.2026. Verfasst von Hang Lei und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hormone receptor-positive breast cancer is the most prevalent molecular subtype of breast cancer. Its therapeutic strategy has progressively evolved from simple endocrine deprivation toward a systematic management model centered on endocrine therapy and integrated with molecularly targeted treatment and dynamic monitoring. This review summarizes the developmental trajectory of endocrine therapy for breast cancer, outlines the classical therapeutic agents and combination strategies used after endocrine resistance, and discusses future directions driven by liquid biopsy, artificial intelligence, and emerging estrogen receptor degradation technologies.
Zitieren
APA
Lei, H., & Gan, L. (2026). Current Status and Future Perspectives of Endocrine Therapy for Breast Cancer: From Classical Approaches to the Evolution of Precision Systemic Medicine. Current Research in Medical Sciences, 5(2), 55-60. https://doi.org/10.63593/crms.2026.03.06
Vancouver
Lei H, Gan L. Current Status and Future Perspectives of Endocrine Therapy for Breast Cancer: From Classical Approaches to the Evolution of Precision Systemic Medicine. Current Research in Medical Sciences. 2026;5(2):55-60. doi:10.63593/crms.2026.03.06
BibTeX
@article{Lei2026,
author = {Lei, Hang and Gan, Lu},
title = {Current Status and Future Perspectives of Endocrine Therapy for Breast Cancer: From Classical Approaches to the Evolution of Precision Systemic Medicine},
journal = {Current Research in Medical Sciences},
year = {2026},
volume = {5},
number = {2},
pages = {55--60},
doi = {10.63593/crms.2026.03.06}
}
EUVIMED